Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CVM Updates

CVM Updates Home
          Animal & Veterinary
          News & Events
          CVM Updates
          FDA Announces Draft Guidance for the Use of Published Literature to Support New Animal Drug ApprovalsCVM Updates FDA Announces Draft Guidance for the Use of Published Literature to Support New Animal Drug Approvals
  
  	
    Share
    Post
    Linkedin

    Email
    PrintEspañol

**Update, March 15, 2023:** The FDA has published final Guidance for Industry #106, “The Use of Published Literature in Support of New Animal Drug Approvals.” Minor editorial changes were made from the draft to final version of the document to improve clarity.


April 19, 2022

Today the U.S. Food and Drug Administration is announcing the availability of draft Guidance for Industry #106 entitled “The Use of Published Literature in Support of New Animal Drug Approvals.”  The document provides guidance to animal drug sponsors on specific areas of the approval process where the available scientific literature may be useful to support the approval of a new animal drug application, an abbreviated new animal drug application, or a conditionally approved new animal drug application.

The original guidance #106, “The Use of Published Literature in Support of New Animal Drug Approval,” was published in 2000 and specifically addressed the use of a single article to support drug approval.  Since its publication, animal drug sponsors have used literature to support various aspects of animal drug development and approval, including early stages of drug development, dosage characterization, microbial food safety, design of the target animal safety evaluation, prediction of potential adverse effects, and substantial evidence of effectiveness.  This draft guidance expands upon the original guidance #106 by considering multiple uses of the scientific literature to support approval of a new animal drug.

Use of published scientific literature makes use of existing knowledge and may reduce the number of animals needed for studies to support approval, and in some cases, may provide a strong basis for drawing conclusions to support an approval.

Although the public may submit comments on any FDA guidance document at any time, we suggest you submit comment(s) on the draft guidance within 60 days to ensure that the FDA considers your comment(s) before it begins work on the final version of the guidance document. To submit comments electronically, visit www.regulations.gov and type the following docket number into the search box: FDA-2021-D-1155.

The public may also submit comments by mail using the address below:

Dockets Management Staff
HFA-305
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852

All submissions received must include the Docket No. FDA-2021-D-1155 for “The Use of Published Literature in Support of New Animal Drug Approvals.”

For more information:

Draft Guidance for Industry #106, “The Use of Published Literature in Support of New Animal Drug Approvals”**Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.**

                                                                                  Content current as of:
      03/15/2023CVM Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop